On 30 July 2026, Sai Parenterals Ltd made its much‑anticipated debut on both the Bombay Stock Exchange and the National Stock Exchange. Issued at ₹0, the stock commanded attention when it listed at ₹400—marking a clean and dramatic entry into the equity markets on its first trading day.
The listing saw no bulk deals reported, indicating a relatively orderly debut with broad-based participation rather than block trades by few investors. Sai Parenterals Ltd is a Hyderabad‑based pharmaceutical formulations company with strengths across branded generics, contract development and manufacturing (CDMO) services, and a diversified therapeutic portfolio spanning injectables to oral dosage forms and more, backed by integrated R&D and manufacturing infrastructure.
| Issue Price | ₹0 |
| Listing Price | ₹400 |
| Closing Price | – |
No bulk deals were reported for Sai Parenterals Ltd on listing day.
See the full profile on the Sai Parenterals Ltd IPO page.
Listing and closing price figures are sourced from official exchange data feeds.